FN1 and myeloid sarcoma: Moreover, fibronectin precludes the ability of laminin, also present in MS lesions (Van Horssen, Bö, Vos, Virtanen, & de Vries, 2005), to facilitate myelin membrane formation (Baron et al., 2014), emphasizing the necessity to remove aggregated fibronectin to allow remyelination.